Is adjuvant radiotherapy warranted in resected pT1-2 node-positive rectal cancer?
نویسندگان
چکیده
منابع مشابه
Is adjuvant radiotherapy warranted in resected pT1-2 node-positive rectal cancer?
BACKGROUND Stage T1-2 rectal cancers are unlikely to have lymph node metastases and neoadjuvant therapy is not routinely administered. Postoperative management is controversial if lymph node metastases are detected in the resected specimen. We studied the outcomes of patients with pT1-2 node-positive rectal cancer in order to determine whether adjuvant radiotherapy was beneficial. METHODS We ...
متن کاملPredicting lymph node metastases in pT1 rectal cancer.
With the widespread introduction of population screening for colorectal cancer in Europe, the number of early rectal cancers is expected to increase. In the past, approximately 25 % of rectal cancers presented with early disease, defined as stage I disease. First, results from population screening in the UK demonstrate an increase to approximately 50 % stage I for screen-detected carcinomas. In...
متن کاملFor Stage II Node-Positive Breast Cancer, is it Worthwhile to Consider Adjuvant Radiotherapy Following Mastectomy?
PURPOSE To evaluate overall survival (OS), progression-free survival (PFS), loco-regional recurrence (LRR), and toxicities for early breast-cancer patients with one to three positive axillary lymph nodes, by the addition of radiotherapy to adjuvant chemotherapy. PATIENTS AND METHODS Patients were eligible for enrollment into the study if they had pathologically proven stages II breast cancer,...
متن کاملAdjuvant docetaxel for node-positive breast cancer.
BACKGROUND We compared docetaxel plus doxorubicin and cyclophosphamide (TAC) with fluorouracil plus doxorubicin and cyclophosphamide (FAC) as adjuvant chemotherapy for operable node-positive breast cancer. METHODS We randomly assigned 1491 women with axillary node-positive breast cancer to six cycles of treatment with either TAC or FAC as adjuvant chemotherapy after surgery. The primary end p...
متن کاملThe role of radiotherapy in node-positive prostate cancer.
Node-positive prostate cancer represents 12% of newly diagnosed prostate cancer cases in the United States; with decreasing use of screening, this proportion is likely to increase. However, very few clinical trials have specifically compared treatment options for this group of patients. Radiotherapy has a potential role as both definitive therapy and adjuvant therapy for node-positive prostate ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Radiation Oncology
سال: 2013
ISSN: 1748-717X
DOI: 10.1186/1748-717x-8-290